Professor Atiene Solomon Sagay - University of Jos Institutional ...
Professor Atiene Solomon Sagay - University of Jos Institutional ...
Professor Atiene Solomon Sagay - University of Jos Institutional ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
FACING THE CHALLENGES OF MOTHERHOOD; THAT THESE LITTLE<br />
ONES MAY LIVE<br />
Text <strong>of</strong> Inaugural Lecture<br />
By<br />
<strong>Pr<strong>of</strong>essor</strong> <strong>Atiene</strong> <strong>Solomon</strong> <strong>Sagay</strong><br />
BSc, MBChB, FWACS, FICS, FRCOG (Lond)<br />
<strong>Pr<strong>of</strong>essor</strong> <strong>of</strong> Obstetrics and Gynaecology<br />
Hon. Consultant Obstetrician and Gynaecologist<br />
<strong>University</strong> <strong>of</strong> <strong>Jos</strong> / <strong>Jos</strong> <strong>University</strong> Teaching Hospital<br />
PMB 2084, <strong>Jos</strong>, Nigeria<br />
Mobile: 08034519740 e-mail: atsagay58@yahoo.com<br />
The natural desire <strong>of</strong> a woman <strong>of</strong> any culture to bear a biological child <strong>of</strong> her own is usually<br />
strong. It is the expression <strong>of</strong> a deep and compelling innate call to motherhood. The<br />
processes <strong>of</strong> pregnancy, child birth and child rearing are unique life-transforming motherhood<br />
experiences that a woman looks forward to as she comes <strong>of</strong> age. I intend to explore these<br />
processes and discuss the numerous challenges women face in Nigeria, by examining five<br />
basic questions:<br />
1. What if a woman fails to conceive or keep pregnancies?<br />
2. What if a pregnancy is unintended and unwanted?<br />
3. How hazardous can pregnancy and childbirth be?<br />
4. Are there any concerns about survival <strong>of</strong> the newborn?<br />
5. Are there emerging challenges to motherhood in the HIV era?<br />
1. What if a woman fails to conceive or fails to keep pregnancies?<br />
Definition <strong>of</strong> infertility<br />
Infertility primarily refers to the biological inability <strong>of</strong> a person to contribute to conception.<br />
For a couple, infertility refers to the inability to achieve conception after 12 months <strong>of</strong><br />
unprotected sex. Infertility may also refer to the condition <strong>of</strong> a woman who is unable to carry<br />
a pregnancy to a state <strong>of</strong> viability.<br />
There are many biological causes <strong>of</strong> infertility and in general, it is estimated that in 30% <strong>of</strong><br />
infertile couples, the problem is with the woman, in another 30% the problem is only with the<br />
man and in a further 30%, the defects are found in both parties while in the final 10% <strong>of</strong><br />
1
couples, no abnormalities are found (unexplained infertility). It is estimated that one out <strong>of</strong><br />
every 6 couples in Nigeria are infertile.<br />
We evaluated 1000 consecutive infertile women in <strong>Jos</strong>, Nigeria and found that 410 (41%) had<br />
never ever conceived (primary infertility) while 590 (59%) have had at least one prior<br />
pregnancy (secondary infertility) (<strong>Sagay</strong> et al 1998). More than 4 out <strong>of</strong> every 10 (42.3%) <strong>of</strong><br />
these women had blocked tubes on both sides (bilateral tubal occlusion). Of the 548 (54.8%)<br />
<strong>of</strong> these infertile women who were found to have pelvic adhesive disease, two-thirds (66%)<br />
had moderate to severe pelvic adhesions for which reconstructive surgical outcome is poor.<br />
What this means is that a large proportion (about 40%) <strong>of</strong> infertile women in Nigeria have<br />
badly damaged reproductive organs for which assisted conception in the form <strong>of</strong> in-vitro<br />
fertilization and embryo transfer (a.k.a. test tube baby) is required. The prevailing cost <strong>of</strong> this<br />
procedure in Nigeria (about 700,000 Naira) is however out <strong>of</strong> the reach <strong>of</strong> most infertile<br />
couples in this country.<br />
On the male side, we studied the semen quality <strong>of</strong> male partners <strong>of</strong> infertile couples in <strong>Jos</strong><br />
(Imade et al. 2000). In all, we analysed the semen <strong>of</strong> 428 male partners <strong>of</strong> infertile women<br />
using the World Health Organisation (WHO) guidelines. The findings revealed that 124<br />
(29%) <strong>of</strong> the men had normal semen parameters (normozoospermia) while 304 (71%) had<br />
abnormal semen quality. The semen abnormalities comprised; 39 (9.1%) with complete<br />
absence <strong>of</strong> spermatozoa (azoospermia), 89 (21%) with significantly reduced population <strong>of</strong><br />
spermatozoa (oligozoospermia), 22 (5.1%) with poor movement (asthenozoospemia) and 18<br />
(4.2%) with abnormal physical forms (teratozoospermia). Another 134 (31.5%) men had<br />
various combinations <strong>of</strong> these seminal abnormalities. The findings suggested that the male<br />
partner is a significant contributor to the problem <strong>of</strong> infertility in <strong>Jos</strong>.<br />
Psycho-social consequences <strong>of</strong> infertility<br />
A Yoruba adage says “Omo laso”, meaning children are clothes, without them you are<br />
naked. Infertile couples feel insecure and vulnerable to societal stigmatization.<br />
The psycho-social challenge faced by infertile women is age-long. Evidence from<br />
biblical time shows that women have contemplated suicide as a response to their<br />
continued barrenness. Rachael, wife <strong>of</strong> Jacob considered live worthless without a<br />
child <strong>of</strong> her own: [Gen 30:1 And when Rachel saw that she bore Jacob no children,<br />
Rachel envied her sister. And she said to Jacob, Give me sons, or else I will die].<br />
Anthropologists who worked in different communities in the South-south region <strong>of</strong> Nigeria<br />
concluded that; "the necessity for a woman to have a child remains basic in this region.<br />
Motherhood continues to define an individual woman's treatment in her community, her selfrespect,<br />
and her understanding <strong>of</strong> womanhood" (Hollos et al 2009).<br />
In focus group discussions on the social meaning <strong>of</strong> infertility in south-western Nigeria,<br />
(Okon<strong>of</strong>ua et al.1997) reported the following community perceptions;<br />
that infertility is not <strong>of</strong>ten discussed, and if at all, must be discussed carefully and<br />
privately. This was largely to avoid embarrassing those who were infertile.<br />
that an infertile person would be extremely sensitive to any discussion about children<br />
or pregnancy, and would assume that even comments in casual conversations were<br />
2
meant to make fun <strong>of</strong> them. This is in the context <strong>of</strong> the belief that a person without<br />
children has failed in a fundamental way.<br />
that women are most <strong>of</strong>ten blamed for the infertility problem. There are many who<br />
believe that a man cannot be infertile, as fertility and potency are <strong>of</strong>ten thought to be<br />
synonymous.<br />
that a common consequence <strong>of</strong> a couple's infertility is the expulsion <strong>of</strong> the woman<br />
from the husband's house, with or without divorce. People most commonly responded<br />
by saying the husband would ‗send her packing‘. Thus, having children is clearly<br />
more important than loyalty to one's spouse, which is evidenced by the common<br />
practice <strong>of</strong> divorce because <strong>of</strong> childlessness, or forceful ejection <strong>of</strong> the wife from the<br />
husband's home, either by the husband himself or by his family.<br />
that infertile women are <strong>of</strong>ten excluded from inheriting property, from decisionmaking<br />
in the family, and from any type <strong>of</strong> financial or social security.<br />
that it is common for people to avoid those women known to be infertile, and women<br />
<strong>of</strong>ten tell their children to avoid these women, either because they think the women<br />
might harm their children because <strong>of</strong> their bitterness, or because they might not know<br />
how to look after other children properly.<br />
that there are strong beliefs that some infertile women were witches, had given birth to<br />
children in another world, and taken a secret vow never to bear children on earth. This<br />
belief justifies the attempt to ostracize these women, and to expel them from their<br />
households.<br />
that <strong>of</strong>ten, any subsequent misfortune <strong>of</strong> the woman or family which would ordinarily<br />
be taken in isolation may instead be attributed to her infertility and/or witchcraft.<br />
A woman‘s ability to make decisions within the family, and her ability to inherit her<br />
husband‘s property are almost exclusively dependent upon fertility.<br />
Clearly, infertile women in the Nigerian socio-cultural setting face tremendous challenges<br />
and perhaps as a consequence, there is a high prevalence <strong>of</strong> psychological problems among<br />
infertile women.<br />
In a Nigerian study, nearly one-third <strong>of</strong> infertile women were found to have diagnosable<br />
psychopathology, mainly depressive episode and generalized anxiety disorder. Compared<br />
with the control group, the infertile women experienced poorer marital relationships and<br />
polygamy was found to have a close association with psychopathology. (Aghanwa et al.1999)<br />
A recent article in the Canadian Medical Association Journal reported the finding that<br />
motherhood appears to protect against suicide, with increasing numbers <strong>of</strong> children<br />
associated with decreasing rates <strong>of</strong> death from suicide. Having children may protect against<br />
suicide because children may increase a mother's feelings <strong>of</strong> self-worth. Children may also<br />
provide emotional and material support to a mother and provide her with a positive social<br />
role. As well, motherhood may enhance social networks and social support.<br />
Recurrent pregnancy losses (Habitual abortion)<br />
There is no experience more difficult than having to go through a miscarriage during<br />
pregnancy. Miscarriage is not only physically taxing, but very emotionally challenging, as<br />
well. Yet, pregnancy loss can be even harder to deal with when it occurs time and time again.<br />
3
Known as recurrent pregnancy loss, repeated miscarriage is difficult for both partners<br />
involved. It can also make fertility treatments particularly challenging.<br />
Recurrent pregnancy loss occurs when a women loses three or more consecutive pregnancies.<br />
The majority <strong>of</strong> recurrent pregnancy losses occur early in pregnancy, typically during the first<br />
half <strong>of</strong> pregnancy. Recurrent pregnancy loss is very difficult for couples to experience,<br />
especially because a cause for these miscarriages is <strong>of</strong>ten never determined. Nevertheless, by<br />
undergoing specific fertility testing and treatment, there is hope that couples who have<br />
experienced multiple miscarriages will go on to welcome a healthy child <strong>of</strong> their own.<br />
Fortunately, recurrent pregnancy loss is relatively rare as fewer than 3% <strong>of</strong> couples go<br />
through more than three miscarriages in a row. It is more likely to occur in older women who<br />
have had two previous pregnancy losses and engaged in certain life-styles such as smoking,<br />
heavy drinking and drug use.<br />
Unfortunately, it is difficult to pinpoint the underlying cause <strong>of</strong> pregnancy loss. In fact, more<br />
than 50% <strong>of</strong> couples that experience the problem never find out what is responsible for their<br />
miscarriages. However, there are a number <strong>of</strong> conditions that do underlie some cases <strong>of</strong><br />
recurrent miscarriage. They include genetic factors, structural uterine problems, hormonal<br />
imbalance and blood clotting disorders.<br />
2. What if a pregnancy is unintended and unwanted?<br />
Each year, thousands <strong>of</strong> Nigerian women have unintended pregnancies that end in illegal<br />
abortion. Many <strong>of</strong> such procedures occur under unsafe conditions, contributing to maternal<br />
morbidity and mortality. To highlight this challenge, permit me to share an experience<br />
during my residency training.<br />
It was about 9.00pm on a cold April night in mid-1980s, I was on my first call duty as a<br />
resident doctor in the <strong>Jos</strong> university teaching hospital, <strong>Jos</strong>, and I was asked to review and<br />
admit a young lady who was said to be having vaginal bleeding. She was a university<br />
undergraduate. On the couch, I found a pretty, young lady with a stylish hair do, who was<br />
very pale, cold, motionless and stiff. My examination confirmed that she was dead. I tried to<br />
conceal my horror and politely told the porter to take her back to the casualty <strong>of</strong>ficer and<br />
demonstrated to him that she was brought in dead and could not be admitted to the<br />
gynaecology ward. The brief history suggested that she had a termination <strong>of</strong> pregnancy<br />
somewhere in town that evening. That night, as I reflected on the scene, I realised I had just<br />
witnessed an avoidable maternal death. This experience remained on my mind all through my<br />
residency training and served as a constant reminder <strong>of</strong> how hazardous being a woman in<br />
Nigeria can be.<br />
Abortion in Nigeria is illegal except to save a woman‘s life. Of the estimated 6.8 million<br />
pregnancies that occur annually in Nigeria, one in five is unplanned and half <strong>of</strong> these end in<br />
an induced abortion. (Guttmacher Institute 2008) Abortion is therefore common in Nigeria<br />
and most procedures are performed under unsafe, clandestine conditions. In 1996, an<br />
estimated 610,000 abortions occurred (25 per 1000 women <strong>of</strong> childbearing age), <strong>of</strong> which<br />
142,000 resulted in complications severe enough to require hospitalization. The number <strong>of</strong><br />
abortions is estimated to have risen to 760,000 in 2006 (Bankole et al. 2006). Unsafe<br />
abortions are a major reason Nigeria‘s maternal mortality ratio – 1,100 deaths per 100,000<br />
live births- is one <strong>of</strong> the highest in the world (WHO 2007). According to conservative<br />
4
estimates, more than 3,000 women die annually in Nigeria as a result <strong>of</strong> unsafe abortion<br />
(Henshaw SK et al 2008).<br />
In countries like Nigeria with low contraceptive uptake, a high rate <strong>of</strong> unintended pregnancies<br />
and poor access to safe maternal healthcare services, each pregnancy puts a woman‘s life at<br />
considerable risk. Women in Africa experience a 1 in 26 (1 in 18 in Nigeria) lifetime risk <strong>of</strong><br />
dying from pregnancy- or childbirth-related complications. This is compared to a 1 in 7,300<br />
lifetime risk for their counterparts in developed countries. Among a total <strong>of</strong> 171 countries for<br />
which estimates were made, the adult lifetime risk <strong>of</strong> maternal death (the probability that a<br />
15-year-old female will die eventually from a maternal cause) was highest in Nigeria‘s<br />
northern neighbour Niger (1 in 7 ), in stark contrast to Ireland, which had the lowest lifetime<br />
risk <strong>of</strong> 1 in 48,000 (WHO 2005).<br />
The likelihood <strong>of</strong> complications during pregnancy and delivery is increased in the face <strong>of</strong>: too<br />
many pregnancies, too short an interval between pregnancies, having a pregnancy too early in<br />
life, or having a pregnancy too late in life.<br />
These conditions can negatively affect a woman‘s long-term health by depleting her<br />
nutritional and overall health status— contributing to anaemia, fatigue, increased blood<br />
pressure and decreased immunity to diseases such as malaria and reproductive tract<br />
infections. These factors can also increase the risk <strong>of</strong> excessive blood loss immediately after<br />
delivery, birth injury, miscarriage, or stillbirth.<br />
Clearly, maternal and neonatal deaths can be prevented by (1) limiting the number <strong>of</strong><br />
pregnancies each woman experiences during her lifetime and (2) improving access to<br />
reproductive and maternal healthcare—particularly antenatal care, skilled attendance at<br />
delivery, emergency obstetric care, postpartum care, and post-abortion care. Making family<br />
planning a component <strong>of</strong> safe motherhood programs, should help women limit their overall<br />
fertility and reduce the number <strong>of</strong> times they are at risk for maternal death; space births,<br />
thereby allowing their bodies to recover from previous pregnancies; and time their<br />
pregnancies. These services must also be accessible to youths.<br />
Over the last 25 years, the <strong>Jos</strong> <strong>University</strong> Teaching Hospital (JUTH), <strong>Jos</strong> has <strong>of</strong>fered family<br />
planning services to all comers and has built tremendous human and institutional capacity. In<br />
the mid 1980s, the department <strong>of</strong> obstetrics and gynaecology at JUTH established a voluntary<br />
surgical contraception unit principally for the provision <strong>of</strong> female sterilization services. The<br />
unit remains one <strong>of</strong> the most active in the country and a number <strong>of</strong> reports have been<br />
published (Otubu et al 1990, Aisien et al 2001, Aisien et al 2002). With the advent <strong>of</strong> novel<br />
contraceptive implants in the 1980s and 1990s, and the instant popularity <strong>of</strong> this non-sex<br />
related, long-term, reversible contraceptive method among our clients, a number <strong>of</strong> studies on<br />
the safety pr<strong>of</strong>ile among Nigerian women were undertaken in the department.<br />
The effect <strong>of</strong> Norplant on serum lipids and lipoproteins (agents that are incriminated in heart<br />
and vascular diseases) was studied by Otubu et al. (1993) Serum triglycerides and total<br />
cholesterol were reduced. High density lipoprotein-cholesterol (HDL-chol) exhibited<br />
statistically significant reduction and low density lipoprotein-cholesterol (LDL-chol) was<br />
significantly elevated at 6 months. The changes in lipid pr<strong>of</strong>ile with regards to cardiovascular<br />
morbidity were mixed. Norplant use was not associated with adverse lipid pr<strong>of</strong>ile.<br />
5
We studied the effects <strong>of</strong> Norplant® on the electrical activity <strong>of</strong> the heart and showed a<br />
tendency to significant prolongation <strong>of</strong> ECG intervals (a tendency to cause heart blocks)<br />
(<strong>Sagay</strong> et al 2002, Okeahialam et al 2004). Although these ECG changes appeared<br />
innocuous, we advised that patients with pre-morbid cardiac conditions should use alternative<br />
contraceptives until these effects are clearly elucidated. Norplant® did not show any<br />
adverse effects on diastolic and systolic blood pressures over time.<br />
Of additional note are the findings that Norplant use is associated with the depletion <strong>of</strong><br />
platelet counts (Aisien et al 2002), weight gain after 2 years <strong>of</strong> use (<strong>Sagay</strong> et al 2008 ) and<br />
mild but reversible impairment <strong>of</strong> glucose metabolism (<strong>Sagay</strong> et al 2000).<br />
The effect <strong>of</strong> Norplant® use on the bone quality <strong>of</strong> Nigerian women using quantitative<br />
ultrasound measurements and serum markers <strong>of</strong> bone turnover (VanderJagt et al 2005)<br />
We used calcaneal ultrasound to compare the bone quality <strong>of</strong> Nigerian women between 25<br />
and 50 years <strong>of</strong> age who had Norplant implants for 1-4 years to that <strong>of</strong> women who were not<br />
using any form <strong>of</strong> hormonal contraceptive. The mean stiffness index <strong>of</strong> women who had<br />
Norplant implants for as long as 4 years was not significantly different from that <strong>of</strong> controls.<br />
However, serum markers <strong>of</strong> bone turnover were significantly decreased in women with<br />
Norplant implants compared to age-matched controls. Serum bone-specific alkaline<br />
phosphatase was significantly decreased in subjects with Norplant implants for 1 year and<br />
serum N-Telopeptidase was significantly decreased in subjects with implants for 3 years. We<br />
conclude that although levonorgestrel contraceptive decreased overall bone turnover, it had<br />
no deleterious effect on the bone quality <strong>of</strong> women using Norplant implants for up to 4 years.<br />
(VanderJagt et al 2005).<br />
Overall, Norplant® use in our women was not associated with any serious adverse effects.<br />
Contraceptive implants have remained popular in our family planning clinics today.<br />
3. How hazardous can pregnancy and childbirth be?<br />
If a mother dies, the infant has little chance <strong>of</strong> survival<br />
Maternal mortality: This is defined as the death <strong>of</strong> a woman while pregnant or within 42 days<br />
<strong>of</strong> termination <strong>of</strong> pregnancy, irrespective <strong>of</strong> the duration and the site <strong>of</strong> the pregnancy, from any<br />
cause related to or aggravated by the pregnancy or its management, but not from accidental or<br />
incidental causes.<br />
Worldwide, every minute a woman dies from pregnancy-related complications.<br />
Maternal mortality ratio: The number <strong>of</strong> maternal deaths per 100,000 live births.<br />
The maternal mortality ratio in Nigeria is 545 deaths per 100,000 live births. (NDHS 2010)<br />
Maternal morbidity: Refers to serious disease, disability or physical damage such as fistula,<br />
caused by pregnancy-related complications.<br />
6
For every woman who dies, 15 to 30 live but suffer chronic disabilities, the worst <strong>of</strong><br />
which is obstetric fistula.<br />
The vast majority <strong>of</strong> women in Nigeria who desire to conceive will conceive within a year and<br />
the pregnancies will develop normally and end with an uneventful vaginal delivery. However, a<br />
number <strong>of</strong> factors conspire to endanger maternal lives in this country. Permit me to mention<br />
these factors without much elaboration.<br />
Risk factors for maternal mortality in Nigeria<br />
1. Susceptible social context:<br />
The social context that contributes to high mortality and morbidity includes a culture<br />
that undervalues women; control <strong>of</strong> women by men; seclusion <strong>of</strong> wives that limits<br />
access to medical care; female illiteracy; early marriage and pregnancy; high rates <strong>of</strong><br />
obstructed labor; directly harmful traditional medical beliefs and practices; inadequate<br />
facilities to treat obstetric emergencies; a declining economy; and a corrupt, inefficient<br />
political culture (Wall LL 1998), additionally, restrictive abortion laws and a<br />
dysfunctional criminal justice system.<br />
2. Non- booking for antenatal care.<br />
3. Ineffective antenatal care.<br />
4. Delivery without skilled attendant.<br />
5. Delays in getting pr<strong>of</strong>essional medical service.<br />
a. Delay by patient in seeking medical care [Individual patient and community].<br />
b. Delay in arriving at a medical facility [communication and transportation<br />
system].<br />
c. Delay in the provision <strong>of</strong> appropriate care at the medical facility [health<br />
personnel and institutional].<br />
Globally, each year there are at least half a million maternal deaths, 3.2 million stillborn<br />
babies, 4 million neonatal deaths. The majority <strong>of</strong> these deaths are avoidable. A total <strong>of</strong> 11–<br />
17% <strong>of</strong> maternal deaths occur during childbirth itself; 50–71% occur in the post-partum<br />
period. The time spent in labour and giving birth, the critical moments when a joyful event<br />
can suddenly turn into an unforeseen crisis, needs more attention, as does the <strong>of</strong>ten-neglected<br />
post-partum period. These periods account not only for the high burden <strong>of</strong> post-partum<br />
maternal deaths, but also for the associated large number <strong>of</strong> stillbirths and early newborn<br />
deaths.<br />
A total <strong>of</strong> 98% <strong>of</strong> stillbirths and newborn deaths occur in low- and middle-income countries:<br />
obstetric complications, particularly in labour, are responsible for perhaps 58% <strong>of</strong> them. The<br />
care that can reduce maternal deaths and improve women‘s health is also crucial for<br />
newborns‘ survival and health.<br />
7
In developed countries, the advent <strong>of</strong> modern obstetric care in the late 1930s gradually moved<br />
the process <strong>of</strong> childbirth from home to institutional settings, with post-partum follow-up and<br />
care by a skilled health-care provider. In most developing countries including Nigeria, the<br />
majority <strong>of</strong> women deliver at home without skilled health-care providers. The Nigerian<br />
Demographic and Health Survey 2008 reported that in the North-central zone <strong>of</strong> Nigeria,<br />
65% <strong>of</strong> pregnant women receive antenatal care while only 41% deliver in health facility<br />
(NDHS 2010). In Plateau State, Nigeria in 2004, a total <strong>of</strong> 71,655 women attended at least<br />
one antenatal visit but only 22,640 delivered in health facilities, indicating that over twothirds<br />
<strong>of</strong> women who attend antenatal care still deliver at home. Little wonder that we<br />
reported a maternal mortality ratio <strong>of</strong> 740 maternal deaths / 100,000 births (Ujah et.al 2005).<br />
The challenges to be met are not new technologies or new knowledge about effective<br />
interventions, because we mostly know what needs to be done to save the lives <strong>of</strong> mothers<br />
and newborns. The real challenges are how to deliver services and scale up interventions,<br />
particularly to those who are vulnerable, hard to reach, marginalized and excluded. Effective<br />
health interventions exist for mothers and babies such as post-abortal care, emergency<br />
obstetrics care, immunization, nutrition counselling and reproductive health services.<br />
However, none will work if political will is absent where it matters most: at national, state<br />
and local government levels.<br />
A key constraint limiting progress is the gap between what is needed and what exists in terms<br />
<strong>of</strong> skills and geographical availability <strong>of</strong> human resources at local, state and national levels.<br />
The Midwifery service scheme which is being implemented by the federal government<br />
through the national primary health care development agency (NPHCDA) is a commendable<br />
step. The table below highlights the nursing personnel gaps in PHCs in all 17 local<br />
government areas <strong>of</strong> Plateau State (Table 1).<br />
Other challenges are how to address deteriorating infrastructures; how to maintain stocks <strong>of</strong><br />
drugs, supplies and equipment in the face <strong>of</strong> increased demand; lack <strong>of</strong> transport; ineffective<br />
referral to and inadequate availability <strong>of</strong> 24-hour quality services – particularly emergency<br />
obstetric care services – and weak management systems. We need to challenge our policymakers<br />
and unit heads to refocus on the development <strong>of</strong> viable organizational strategies for<br />
monitoring and evaluation that ensure a continuum <strong>of</strong> care and account for every birth and<br />
death.<br />
South Africa is one <strong>of</strong> the few developing countries with a national confidential inquiry into<br />
maternal deaths. 164 health facilities obtain audit data for stillbirths and neonatal deaths, and<br />
a new audit network does so for child deaths. Three separate reports have been published,<br />
providing valuable information about avoidable causes <strong>of</strong> death for mothers, babies, and<br />
children. The leaders <strong>of</strong> these three reports have united to prioritise actions to save the lives<br />
<strong>of</strong> South Africa's mothers, babies, and children (Bradshaw et al 2008).<br />
Nigeria should establish a national confidential inquiry into maternal deaths and mandatorily<br />
obtain audit data for stillbirth, neonatal and child deaths. Although Edo and Ondo States have<br />
already promulgated the enabling laws, I advocate a national buy in and leadership at the<br />
national level.<br />
8
Table 1: Nursing personnel gaps in PHCs in Plateau State (2009)<br />
As we plan to obtain these relevant data, clear framework and procedures for data use to<br />
improve national vital health statistics should be developed. Audit is powerful, but only if the<br />
data lead to action.<br />
Nigeria‘s most recent maternal mortality ratio <strong>of</strong> 545deaths/100,000 live births gives the<br />
impression that things have substantially improved.<br />
Before we leave with such impression, let me outline the findings <strong>of</strong> two recent study by<br />
Mairiga and Saleh (2009) and Kullima et al (2009) that reported maternal mortality in<br />
Bauchi Specialist Hospital, Bauchi, Bauchi State and Federal Medical Centre, Nguru, Yobe<br />
State.<br />
Bauchi, Bauchi State:<br />
Maternal Mortality Ratio (MMR) for the period under review was 1,732 per 100, 000 live<br />
births. Six hundred and twenty one (621) <strong>of</strong> the deaths (81.0%) occurred in 12,067 unbooked<br />
deliveries giving a maternal mortality ratio <strong>of</strong> 5,146 per 100,000 for unbooked mothers (11fold<br />
increase in maternal mortality over booked mothers). The annual MMR was highest for<br />
the year 2006 (2,586 per 100,000).<br />
Nguru, Yobe State:<br />
At Federal Medical Centre, Nguru, a total <strong>of</strong> 112 maternal deaths were recorded in 3,931<br />
deliveries giving a MMR <strong>of</strong> 2849/100,000 deliveries in the 5-year period studied. The highest<br />
MMR <strong>of</strong> 6234/100,000 was observed in 2003, with remarkable decline to 1837/100,000 in<br />
2007. Eclampsia was the leading cause, accounting for 46.4% <strong>of</strong> the maternal deaths,<br />
followed by sepsis and postpartum haemorrhage (PPH) contributing 17% and 14.3%,<br />
9
espectively. Lack <strong>of</strong> antenatal care (Unbooked status) and illiteracy were the significant<br />
determinants <strong>of</strong> maternal mortality.<br />
When we compare these maternal mortality figures with 3/100,000 deliveries in Sweden,<br />
4/100,000 deliveries in Spain, 5/100,000 deliveries in Switzerland and 8/100,000 deliveries in<br />
the United Kingdom (WHO 2005), they become terribly disturbing. These staggering<br />
maternal mortality figures are a reflection <strong>of</strong> the premium placed on the lives <strong>of</strong> women in<br />
this country. These women do not die <strong>of</strong> diseases that can’t be treated or complications that<br />
can’t be prevented. To quote Mahmoud Fathalla, former president <strong>of</strong> the International<br />
Federation <strong>of</strong> Obstetricians and Gynecologists, “they die because societies have yet to determine<br />
that their lives are worth saving”. Sadly, if a woman does not survive, her child has little<br />
chance <strong>of</strong> survival.<br />
Vesico-Vaginal Fistula (VVF)<br />
For every woman who dies at childbirth, 15 to 30 live but suffer chronic disabilities, the<br />
worst <strong>of</strong> which is obstetric fistula. Each year some 50,000-100,000 women sustain an<br />
obstetric fistula in the act <strong>of</strong> trying to bring forth new life. Fistula is a preventable and<br />
treatable condition, one that no woman should have to endure. Yet more than two million<br />
women remain untreated in developing countries.<br />
Obstetric fistula is the most devastating <strong>of</strong> all pregnancy-related disabilities. It usually occurs<br />
when a young, poor woman has an obstructed labour and cannot get a Caesarean section<br />
when needed. The obstruction can occur because the woman‘s pelvis is too small, the baby‘s<br />
head is too big, or the baby is badly positioned. The woman can be in labour for three days or<br />
more without medical help. The baby usually dies. If the mother survives, she is left with<br />
extensive tissue damage to her birth canal that renders her incontinent.<br />
The results are life shattering. The woman is unable to stay dry and the smell <strong>of</strong> urine or<br />
faeces is constant and humiliating. Nerve damage to her legs can also make it difficult to<br />
walk. Rather than being comforted for the loss <strong>of</strong> her child, she is <strong>of</strong>ten rejected by her<br />
husband, shunned by her community and blamed for her condition. Women who remain<br />
untreated not only face a life <strong>of</strong> shame and isolation, but may also face a slow, premature<br />
death from infection and kidney failure. While some women receive support from their<br />
families, others are forced to beg or turn to sex work for a living.<br />
During obstructed labour, the prolonged pressure <strong>of</strong> the baby‘s head against the mother‘s<br />
bony pelvis cuts <strong>of</strong>f the blood supply to the s<strong>of</strong>t tissues <strong>of</strong> her vagina, bladder and rectum that<br />
are trapped between the harder (bony) structures. The injured s<strong>of</strong>t tissue soon rots away,<br />
leaving a hole, or fistula. If the hole is between the woman‘s vagina and bladder, she loses<br />
control over her urination, and if it is between her vagina and rectum, she loses control <strong>of</strong> her<br />
bowels. Reconstructive surgery can mend this injury, but most women are either unaware that<br />
treatment is available or cannot access or afford it. Fistula surgical repair has up to 90 per<br />
cent success rates and costs between N20, 000 to N60, 000. In supported VVF repair and<br />
rehabilitation centres, most services are provided free <strong>of</strong> charge. ECWA Evangel Hospital is<br />
one such centre in <strong>Jos</strong>, Nigeria.<br />
In the words <strong>of</strong> DR. ANDREW ARKUTU ―An obstetric fistula is more than a hole. For those<br />
afflicted, it is a comprehensive social and psychological disaster, resulting from a dramatic<br />
failure in obstetric care.‖<br />
10
The tragedy <strong>of</strong> an obstetric fistula is that it touches a young girl at the very essence <strong>of</strong> her<br />
being - her childbearing capabilities. It touches her when she is too young to understand what<br />
has happened. . . If not operated on or helped, recurrent urinary tract infections can lead to<br />
kidney problems and eventual renal failure and death. So, though the girl with obstetric<br />
fistula is a survivor <strong>of</strong> maternal mortality statistics in the first light, is she really, if she dies<br />
later, unwanted, humiliated and lonely in some remote village hut?<br />
Clinical Audit <strong>of</strong> Primary Health Centres in <strong>Jos</strong>, Nigeria<br />
In 1978 at Alma Ata, the United Nations adopted primary health care, as a global strategy for<br />
promoting health for all by the year 2000, a policy that was adopted by Nigeria in 1988. The<br />
emphasis was on preventive rather than curative medicine. The federal ministry <strong>of</strong> health<br />
through the states and local governments established Primary Health Centres (PHCs) in all<br />
local government areas in this country. One <strong>of</strong> the aims was to improve access to affordable<br />
antenatal care for pregnant women in order to achieve a substantial reduction in maternal and<br />
perinatal deaths. Despite these efforts by government, maternal and perinatal death rates did<br />
not decline. Pregnant women are frequently referred late from PHCs to tertiary institutions,<br />
resulting in adverse obstetric outcomes (Kuti et al 2001). The high proportion <strong>of</strong> avoidable<br />
maternal deaths in the maternity unit <strong>of</strong> JUTH resulting from late referrals from PHCs around<br />
<strong>Jos</strong> prompted us to conduct a clinical audit <strong>of</strong> these centres (<strong>Sagay</strong> et al 2005).<br />
The study evaluated the quality <strong>of</strong> antenatal care services in 12 randomly selected PHCs in<br />
the <strong>Jos</strong>/Bukuru metropolis. The findings indicated that:<br />
High risk obstetric cases (previous caesarean section, hypertension, and previous post<br />
partum haemorrhage) were being booked and seen at the PHCs.<br />
Over two-thirds <strong>of</strong> pregnant women receiving antenatal care at PHCs did not have<br />
blood pressure surveillance through pregnancy.<br />
Routine malaria prophylaxis during pregnancy was not given in any <strong>of</strong> the PHCs.<br />
About two-thirds <strong>of</strong> pregnant women receiving antenatal care did not have any<br />
documented attempt to ascertain the gestational age.<br />
No pregnant woman was screened for sickle cell disease (sickling test or genotype).<br />
The principal examination that almost all patients had was weighing which has been<br />
shown to have little impact on obstetric outcome.<br />
Undoubtedly, we considered antenatal care provided at the PHCs in the <strong>Jos</strong> area substandard<br />
and capable <strong>of</strong> putting the health <strong>of</strong> pregnant women at unacceptable risk. We made the<br />
following recommendations:<br />
1. A periodic exchange <strong>of</strong> staff between primary, secondary and tertiary health<br />
institutions should be encouraged as a way <strong>of</strong> improving the knowledge base and<br />
skills <strong>of</strong> healthcare providers in these facilities.<br />
2. Healthcare workers in PHCs should be encouraged to attend periodic update courses.<br />
3. Regular internal and periodic external audit <strong>of</strong> the clinical activities at PHCs should<br />
be considered.<br />
11
4. Posters <strong>of</strong> high-risk obstetric factors requiring referral should be placed in strategic<br />
areas in the consulting rooms at PHCs to serve as reminders for the healthcare<br />
workers.<br />
5. Basic infrastructure in PHCs should be provided and maintained.<br />
6. Each local government area should consider appointing a supervising consultant<br />
obstetrician to maintain the standard <strong>of</strong> services in its PHCs.<br />
PHCs in <strong>Jos</strong> are better staffed in comparison to PHCs in more rural communities in the State<br />
(see Table 1). The poor antenatal services observed in PHCs around <strong>Jos</strong> are therefore likely to<br />
be a more generalized problem. Sub-standard care in this situation does not only put pregnant<br />
women‘s lives at risk but it represents a missed opportunity to impact positively on the poor<br />
maternal and perinatal health statistics in the area.<br />
4. Are there any concerns about survival <strong>of</strong> the newborn?<br />
The global burden <strong>of</strong> newborn illness shows that a disparity <strong>of</strong> up to 30-folds exists between<br />
countries with highest and lowest newborn death statistics. Four million babies die in<br />
developing countries annually and about 42% <strong>of</strong> these deaths are due to infections. Other<br />
major causes include perinatal asphyxia (21%), birth injuries (11%), prematurity and low<br />
birth weight (10%) and congenital abnormalities (11%). It was also observed that two-thirds<br />
<strong>of</strong> the deaths in the neonatal period occur in the first week; among these deaths, two-thirds<br />
occurred within the first 24 hours.<br />
skilled care at facility levels such as emergency obstetric care services are<br />
recommended for saving maternal and newborn lives (Bhutta et al 2008).<br />
scale-up <strong>of</strong> community and household care are necessary for improving<br />
newborn and child survival<br />
Programmes that are necessary for the reduction in neonatal morbidity and mortality rates are<br />
for countries to employ rational mix <strong>of</strong> quality clinical services, effective public health<br />
measures and inexpensive community-based interventions in public and private sectors and to<br />
scale-up known cost-effective interventions such as the mother-baby packages. (Sule and<br />
Onayade 2006). Strengthening Maternal Newborn and Child Health services at the primary<br />
health-care level should be a priority for countries to reach their Millennium Development<br />
Goal targets for reducing maternal and child mortality.<br />
5. Are there emerging challenges to motherhood in the HIV era?<br />
Trend <strong>of</strong> HIV prevalence in women in Plateau State<br />
Our study <strong>of</strong> the HIV epidemic in pregnant women in Nigeria started in 1999 when we<br />
reported the yearly trend <strong>of</strong> HIV sero-prevalence among pregnant women in <strong>Jos</strong> over a 10year<br />
period (1989 – 1998). A total <strong>of</strong> 11,059 pregnant women were screened and 134 (1.24%)<br />
were HIV positive. The yearly trend showed a rise in HIV sero-prevalence from 0.25% (1 in<br />
394) in 1989 to 3.69% (1 in 27) in 1997(<strong>Sagay</strong> et al 1999). The trend <strong>of</strong> yearly HIV<br />
prevalence among pregnant women from 1989 to 2001 is shown in Figure 1.<br />
12
Figure 1: Diagram shows rising trend <strong>of</strong> HIV infection in pregnant women in <strong>Jos</strong>, Nigeria<br />
% HIV Positive<br />
6<br />
5<br />
4<br />
3<br />
2<br />
1<br />
0<br />
0.25<br />
Yearly HIV Seroprevalence Among Pregnant<br />
Women in <strong>Jos</strong>, Nigeria 1989-2001<br />
0.38 0.4<br />
0.71<br />
1.71<br />
2.21<br />
Year<br />
We believed that the 16-fold rise in prevalence <strong>of</strong> HIV infection among pregnant women in<br />
<strong>Jos</strong> over a 10-year period was a reflection <strong>of</strong> the trend in the general population. In the<br />
absence <strong>of</strong> interventions, 30% to 40% <strong>of</strong> HIV- exposed infants will become HIV infected<br />
through mother-to-child transmission. The implications <strong>of</strong> this rising prevalence <strong>of</strong> HIV in<br />
pregnant women and what it portends for child survival in the absence <strong>of</strong> interventions to<br />
prevent mother-to-child transmission (PMTCT) provided the impetus for our further studies<br />
to identify local risk factors and possible intervention strategies.<br />
Documentation <strong>of</strong> higher prevalence <strong>of</strong> cervical abnormalities in <strong>Jos</strong><br />
Another challenge that we documented was the higher prevalence <strong>of</strong> cervical abnormalities<br />
which could not be directly attributed to the increasing HIV epidemic. Cancer <strong>of</strong> the cervix is<br />
essentially a sexually transmitted disease and it occurs more commonly among women who<br />
have delivered many children. Cervical pre-cancer lesions are more common among HIV<br />
infected women when compared with HIV negative controls (40% versus 17%) (Massad et al<br />
1999) and it correlates with lower CD4+ cell counts (Schafer et al 1991). We reported the<br />
doubling (7.7% in 1990 vs 14.6% in 2002) in prevalence <strong>of</strong> CIN in <strong>Jos</strong> over a decade <strong>of</strong><br />
expanding HIV epidemic (<strong>Sagay</strong> et al 2008.) Recently, we also reported a much higher rate<br />
<strong>of</strong> CIN (24.6%) among female sex workers in <strong>Jos</strong> (<strong>Sagay</strong> et al 2009). These findings<br />
highlight anticipated challenges with cervical cancer in the near future if prevention,<br />
screening and treatment interventions are not implemented. With the advent <strong>of</strong> human<br />
papilloma virus vaccine, the prospect <strong>of</strong> achieving wide spread primary prevention cannot be<br />
brighter. The quadrivalent human papillomavirus (HPV) vaccine, marketed under the name<br />
Gardasil®, is a recombinant vaccine that is effective against HPV types 6, 11, 16, and 18.<br />
The vaccine received approval for the prevention <strong>of</strong> cervical, vulvar, and vaginal<br />
intraepithelial lesions and genital warts associated with the vaccine HPV types. The vaccine<br />
is administered to girls aged 9-26 years in 3 doses over a 6-month period. The complete cost<br />
per client is about 400USD or N60, 000.<br />
13<br />
3.21<br />
3.28<br />
3.69<br />
3.92<br />
4.13<br />
4.56<br />
4.82
Risk factors for HIV infection in pregnant women in <strong>Jos</strong><br />
As part the national program for prevention <strong>of</strong> mother-to-child transmission (PMTCT) <strong>of</strong><br />
HIV, the AIDS Prevention Initiative in Nigeria (APIN) developed HIV voluntary counselling<br />
and testing services at JUTH antenatal clinic in October 2001. Between April 2002 and<br />
November 2003, we conducted a study to determine the risk factors for HIV and other<br />
sexually transmitted infections (STIs) among pregnant women participating in the PMTCT<br />
programme at JUTH. During this period, antiretroviral (ARV) intervention for PMTCT using<br />
single-dose Nevirapine was introduced. This study documented risk factors <strong>of</strong> HIV infection<br />
in pregnant women which are outlined below in tables 2a, 2b, 2c and 2d.<br />
HIV Risk Factors in Pregnant Women in Nigeria:<br />
a. Age, religion and alcohol<br />
Among pregnant women in <strong>Jos</strong>, Nigeria, HIV prevalence was lowest in teenagers and the<br />
over 40s. Women aged 20 to 29 years had a 4-fold higher prevalence <strong>of</strong> HIV infection.<br />
Compared to women who reported to be Moslems, women <strong>of</strong> all Christian denominations had<br />
significantly increased risk <strong>of</strong> HIV. This was more so among Pentecostals and Catholics.<br />
Women who admitted to taking alcohol had significantly increased risk <strong>of</strong> HIV.<br />
Table 2a: The associations between age, religion and alcohol use and HIV-1 infection<br />
among pregnant women in <strong>Jos</strong>, Nigeria (<strong>Sagay</strong>, Kapiga, Imade, et al 2005)<br />
Predictor<br />
Age (years completed)<br />
40<br />
Don’t know<br />
Religion<br />
Moslem<br />
Catholic<br />
Pentecostal<br />
Protestant<br />
Traditional/other<br />
Missing<br />
Do you drink alcohol?<br />
No<br />
Yes<br />
Missing<br />
N (%) % HIV<br />
positive<br />
182 (6.8)<br />
618 (23.3)<br />
887 (33.4)<br />
607 (22.8)<br />
276 (10.4)<br />
54 (2.0)<br />
33 (1.2)<br />
802 (30.2)<br />
477 (18.0)<br />
383 (14.4)<br />
953 (35.9)<br />
15 (0.6)<br />
27 (1.0)<br />
24 (93.8)<br />
125 (4.7)<br />
41 (1.5)<br />
b. Marital Status and Husband’s Occupation<br />
14<br />
2.2<br />
8.3<br />
10.9<br />
7.7<br />
5.4<br />
1.9<br />
6.1<br />
5.1<br />
9.6<br />
10.2<br />
9.3<br />
0.0<br />
0.9<br />
7.9<br />
13.6<br />
4.9<br />
Crude OR (95% CI) a Adjusted OR (95%<br />
CI) b<br />
1.00<br />
4.00 (1.43-11.22)<br />
5.46 (1.98-15.03)<br />
3.73 (1.33-10.50)<br />
2.56 (0.83-7.82)<br />
0.84 (0.09-7.67)<br />
2.87 (0.50-16.34)<br />
1.00<br />
1.98 (1.28-3.07)<br />
2.10 (1.33-3.32)<br />
1.91 (1.30-2.80)<br />
-<br />
1.48 (0.34-6.48)<br />
1.00<br />
1.83 (1.07-3.10)<br />
0.59 (0.14-2.48)<br />
1.00<br />
4.57 (1.3-15.46)<br />
4.44 (1.32-14.88)<br />
3.00 (0.86-10.40)<br />
1.69 (0.44-6.43)<br />
0.47 (0.04-5.38)<br />
1.05 (0.01-11.39)<br />
1.00<br />
1.72 (1.01-2.95)<br />
2.57 (1.46-4.52)<br />
1.50 (0.93-2.44)<br />
-<br />
-<br />
Women who were married only once had a low risk <strong>of</strong> HIV. In comparison, the risk <strong>of</strong><br />
HIV was increased among women who reported multiple marriages and in unmarried<br />
women. The risk <strong>of</strong> HIV was also increased among women whose husbands were
ankers or accountants.<br />
Table 2b. The associations between marital status and husband’s occupation, and HIV-1<br />
infection among pregnant women in <strong>Jos</strong>, Nigeria (<strong>Sagay</strong>, Kapiga, Imade, et al 2005)<br />
Predictor<br />
Marital status<br />
Married only once<br />
Married more than once<br />
Not married (single/div/sep)<br />
Missing<br />
Occupation <strong>of</strong> husband/partner<br />
Civil servant<br />
Banker/accountant<br />
Business<br />
Drivers (truck, taxi, motorcycle)<br />
Other<br />
Missing<br />
Not married<br />
N (%) % HIV<br />
positive<br />
2429 (91.4)<br />
161 (6.1)<br />
39 (1.5)<br />
28 (1.1)<br />
830 (31.2)<br />
72 (2.7)<br />
858 (32.3)<br />
181 (6.8)<br />
557 (21.0)<br />
120 (4.5)<br />
39 (1.5)<br />
15<br />
7.4<br />
16.1<br />
23.1<br />
7.1<br />
8.6<br />
20.8<br />
6.9<br />
5.5<br />
7.4<br />
10.0<br />
23.1<br />
Crude OR (95%<br />
CI) a<br />
1.00<br />
2.41 (1.54-3.76)<br />
3.75 (1.75-8.02)<br />
0.96 (0.23-4.08)<br />
1.00<br />
2.81 (1.51-5.22)<br />
0.79 (0.55-1.13)<br />
0.63 (0.32-1.24)<br />
0.85 (0.57-1.27)<br />
1.19 (0.62-2.26)<br />
3.21 (1.46-7.02)<br />
c. Circumcision, No. Of Sex Partners, Sex Network and Perceived Risk <strong>of</strong> HIV<br />
Adjusted OR (95%<br />
CI) b<br />
1.00<br />
3.06 (1.74-5.39)<br />
2.08 (0.67-6.47)<br />
_<br />
1.00<br />
2.88 (1.28-6.45)<br />
1.10 (0.71-1.70)<br />
0.87 (0.40-191)<br />
0.97 (0.60-1.57)<br />
_<br />
_<br />
Women who reported to be circumcised (13.3%) had relatively reduced risk <strong>of</strong> HIV<br />
(OR=0.59, 95% CI=0.36-0.96). Women’s level <strong>of</strong> education and occupation were not<br />
associated with HIV. The risk <strong>of</strong> HIV increased with increasing number <strong>of</strong> sex partners<br />
in the past 5 years. Women who were aware that their last male partner had other sex<br />
partners were at increased risk <strong>of</strong> HIV. About 51% <strong>of</strong> women knew someone who was<br />
living with HIV or died from AIDS, while 17.6% had a close relative who was living with<br />
HIV or died from AIDS. These women had increased risk <strong>of</strong> HIV. Compared to women<br />
who perceived themselves to be at no risk <strong>of</strong> HIV, the risk <strong>of</strong> HIV was significantly<br />
increased in all other women. Women who had abnormal vaginal discharge in the last<br />
12 months were also at increased risk <strong>of</strong> HIV infection.
Table 2c. The associations between selected potential risk factors and HIV-1 infection<br />
among pregnant women in <strong>Jos</strong>, Plateau State, Nigeria. (<strong>Sagay</strong>, Kapiga, Imade, et al 2005)<br />
Predictor<br />
Number <strong>of</strong> sex partners in the last 5 years<br />
1<br />
2<br />
>3<br />
Missing<br />
p-value, test for linear trend<br />
Last male partner has other partners?<br />
No<br />
Yes<br />
Don’t know<br />
What are your chances <strong>of</strong> contracting<br />
HIV/AIDS?<br />
No risk at all<br />
Minimal/small risk<br />
Moderate risk<br />
Great risk<br />
Don’t know<br />
p-value, test for linear trend<br />
Had abnormal genital discharge during the<br />
last 12 months<br />
No<br />
Yes<br />
Don’t know<br />
N (%) % HIV<br />
positive<br />
2003 (75.4)<br />
349 (13.1)<br />
128 (4.8)<br />
177 (6.7)<br />
1680 (63.2)<br />
162 (6.1)<br />
815 (30.7)<br />
1607 (61.7)<br />
388 (14.9)<br />
68 (2.6)<br />
25 (0.9)<br />
518 (19.9)<br />
8866 (70.2)<br />
661 (24.9)<br />
130 (4.9)<br />
16<br />
5.7<br />
13.2<br />
19.5<br />
17.5<br />
5.8<br />
22.8<br />
10.2<br />
4.1<br />
7.2<br />
17.6<br />
20.0<br />
11.0<br />
6.3<br />
14.1<br />
5.4<br />
d. Sexually Transmitted Infections (STIs) and HIV Risk<br />
Crude OR (95% CI) a Adjusted OR<br />
(95% CI) b<br />
1.00<br />
2.49 (1.73-3.85)<br />
3.98 (2.48-6.41)<br />
3.49 (2.27-5.36)<br />
0.001<br />
1.00<br />
4.83 (3.17-7.35)<br />
1.85 (1.36-2.51)<br />
1.00<br />
1.82 (1.15-2.87)<br />
5.00(2.56-9.78)<br />
5.84 (2.12-16.03)<br />
2.89 (1.99-4.18)<br />
Table 2d. The associations between selected potential risk factors and HIV-1 infection<br />
among pregnant women in <strong>Jos</strong>, Plateau State, Nigeria. (<strong>Sagay</strong>, Kapiga, Imade, et al 2005)<br />
Predictor<br />
Had genital ulcer during the last 12<br />
months or at the time <strong>of</strong> exam.<br />
No<br />
Yes<br />
Don’t know or not examined<br />
Candida albicans<br />
Negative<br />
Positive<br />
Samples not provided<br />
Trichomonas vaginalis<br />
Negative<br />
Positive<br />
Samples not provided<br />
Active (recent) syphilis<br />
Negative<br />
Positive<br />
Samples not provided<br />
Disturbance <strong>of</strong> vaginal flora<br />
Normal flora<br />
Mild disturbances<br />
Moderate disturbances<br />
Severe disturbances (Bacterial Vaginosis)<br />
Samples not provided<br />
N (%) % HIV<br />
positive<br />
2422 (91.2)<br />
132 (5.0)<br />
103 (3.9)<br />
2226 (83.8)<br />
391 (14.7)<br />
40 (1.5)<br />
575 (96.9)<br />
41 (1.5)<br />
41 (1.5)<br />
627 (98.8)<br />
7 (0.3)<br />
23 (0.9)<br />
185 (7.0)<br />
1677 (63.2)<br />
288 (10.8)<br />
466 (17.5)<br />
41 (1.5)<br />
17<br />
7.0<br />
28.8<br />
9.7<br />
7.3<br />
13.0<br />
10.0<br />
8.0<br />
14.6<br />
12.2<br />
8.0<br />
42.9<br />
17.4<br />
7.6<br />
6.5<br />
10.4<br />
12.7<br />
12.2<br />
Prevention <strong>of</strong> Mother-to-Child Transmission <strong>of</strong> HIV<br />
Crude OR (95%<br />
CI) a<br />
1.00<br />
5.39 (3.58-8.10)<br />
1.43 (0.73-2.80)<br />
1.00<br />
1.91 (1.37-2.67)<br />
1.41(0.5-4.03)<br />
1.00<br />
1.97 (0.82-4.74)<br />
1.60 (0.62-4.11)<br />
1.00<br />
8.63 (1.92-38.82)<br />
2.42 (0.82-7.19<br />
1.00<br />
0.85 (0.48-1.51)<br />
1.42 (0.73-2.76)<br />
1.77 (0.96-3.26)<br />
1.70 (0.57-5.01)<br />
Adjusted OR (95%<br />
CI) b<br />
1.00<br />
3.35 (2.00-5.61)<br />
-<br />
1.00<br />
2.23 (1.49-3.36)<br />
-<br />
1.00<br />
16.88 (2.88-98.76)<br />
-<br />
1.00<br />
1.68 (0.78-3.62)<br />
2.40 (1.03-5.60)<br />
2.77 (1.25-6.13)<br />
-<br />
Mother-to-child transmission (MTCT) <strong>of</strong> HIV is the most significant source <strong>of</strong> HIV infection in<br />
children below the age <strong>of</strong> 10 years. To prevent mother to child transmission <strong>of</strong> HIV, World<br />
Health Organization recommends a four-pronged strategy. This includes: (i) the primary<br />
prevention <strong>of</strong> HIV infection among parents to be; (ii) the prevention <strong>of</strong> unwanted pregnancies<br />
(including safe abortion where permitted by law) in HIV-infected women; and (iii) the<br />
prevention <strong>of</strong> HIV transmission from infected women to their infants and (iv) the treatment,<br />
care and support <strong>of</strong> infected and affected women, their infants and young children, partners and<br />
families.<br />
Nigeria national response<br />
The expanding HIV epidemic nationally prompted the establishment <strong>of</strong> a national prevention <strong>of</strong><br />
mother-to-child transmission (PMTCT) <strong>of</strong> HIV program in 2001. The program started with a<br />
formative research in 2001 while counselling, testing and the administration <strong>of</strong> single-dose<br />
Nevirapine intervention regimen commenced in 8 tertiary health facilities in July 2002. With<br />
funding support from Center for Disease Control (CDC), Atlanta, USA in2003, interventions<br />
started in 3 additional tertiary facilities, bring the total to 11 sites. Evaluation <strong>of</strong> the program in<br />
2004 showed a national coverage <strong>of</strong> about 1% <strong>of</strong> eligible pregnant women and this poor
coverage was the impetus for scaling up efforts. The national PMTCT Program expansion efforts<br />
enjoyed substantial donor support, and services have currently reached about 650 sites.<br />
Expansion <strong>of</strong> PMTCT services in Plateau State<br />
With support from APIN, we embarked on the expansion <strong>of</strong> PMTCT services in Plateau State in<br />
2004. This project was my sabbatical leave assignment with APIN. We adopted a stepwise<br />
approach as outlined below:<br />
Mapping <strong>of</strong> maternity care services in Plateau State.<br />
Selection <strong>of</strong> phase 1 implementation sites based on; HIV prevalence in facility, volume <strong>of</strong><br />
ANC clientele and geography.<br />
Engagement <strong>of</strong> institutional leadership through advocacy to promote buy-in., Facility<br />
assessment, Renovation, Personnel capacity building (trainings), provision <strong>of</strong> necessary<br />
equipment and commencement <strong>of</strong> PMTCT services using national guidelines and<br />
registers.<br />
Figure 2: New Antenatal Care Bookings by LGAs in 2004<br />
18
Figure 3: Health Facility Deliveries by LGAs in 2004<br />
Figure 4: Health Facility HIV prevalence rates in Plateau State by LGAs in 2004<br />
19
Figure 5: Level <strong>of</strong> PMTCT Services by LGAs in Plateau State 2004<br />
In 2006, this drive snowballed to HIV/AIDS comprehensive treatment and care program<br />
through additional funding from Harvard PEPFAR. Services were decentralization to all the 17<br />
local government areas <strong>of</strong> Plateau State. Service provision in the following areas were<br />
supported: Adult antiretroviral therapy, PMTCT, Paediatric antiretroviral therapy, Infant<br />
feeding and nutrition counseling, Family planning, Cervical cancer screening, Malaria<br />
prophylaxis interventions, Tuberculosis screening and Orphans and vulnerable children (OVC)<br />
support. The diagram below shows the activity pyramid <strong>of</strong> the program.<br />
47<br />
Activity Pyramid<br />
14<br />
1<br />
20<br />
APIN<br />
JUTH<br />
SATELLITES<br />
SITES<br />
PRIMARY HEALTH<br />
CARE FACILITIES<br />
COMMUNITY<br />
Figure 6: Activity Pyramid <strong>of</strong> PMTCT Decentralization in Plateau State, Nigeria
Figure 7: Hub and Spoke Illustration <strong>of</strong> PMTCT Sites in Plateau State, Nigeria<br />
The mapping exercise reported that in 2004, 71,655 pregnant women booked for antenatal care<br />
and 22,640 women delivered in the 193 health facilities providing maternity services in the 17<br />
LGAs <strong>of</strong> Plateau State. In 2004, only 5,500 pregnant women in 2 LGAs accessed PMTCT services,<br />
giving PMTCT coverage <strong>of</strong> 6.5%. Subsequent PMTCT expansion efforts supported principally by<br />
APIN and also by other partners, led to the availability <strong>of</strong> PMTCT services in all 17 LGAs by<br />
2007. In 2008, 42,120 pregnant women accessed PMTCT interventions across Plateau State<br />
giving coverage <strong>of</strong> 47.5% according to 2006 population census. From conservative estimates<br />
based on these figures, about 300 infant HIV infections were averted in Plateau State in 2008<br />
alone.<br />
About 300 infant HIV infections are averted each year in Plateau State<br />
through PMTCT interventions<br />
HIV testing and counseling in labour as entry point for PMTCT<br />
The highest risk <strong>of</strong> mother-to-child transmission (MTCT) <strong>of</strong> HIV-1 infection occurs during<br />
labour and delivery. Findings from clinical trials show that antiretroviral (ARV) prophylaxis,<br />
given to the mother during labour and delivery and to the neonate immediately after birth, can<br />
reduce MTCT <strong>of</strong> HIV by as much as 50% (Moodley D et al 2003).<br />
Thus, provision <strong>of</strong> routine HIV testing to women with unknown HIV status during labour and<br />
delivery can contribute in reducing MTCT. We demonstrated the feasibility <strong>of</strong> providing rapid<br />
HIV testing and counselling, using the “opt out” approach, in the labour ward <strong>of</strong> JUTH (<strong>Sagay</strong> et<br />
al 2006). Among 164 women with unknown HIV status before labour, 14 (8.6%) were detected<br />
to be HIV positive in labour. In all, a total <strong>of</strong> 340 (99.8%) <strong>of</strong> the 431 pregnant women who were<br />
<strong>of</strong>fered HIV testing in labour accepted testing. Of the 235 women who previously tested HIV<br />
negative during pregnancy, 5 (2.1%) were found to be HIV positive in labour (see Table 3). The<br />
practice <strong>of</strong> rapid HIV testing and counselling in labour provides a final opportunity to detect<br />
21
pregnant women with HIV infection, who may require interventions to prevent MTCT. This was<br />
the first study to demonstrate the feasibility <strong>of</strong> this practice in labour ward settings in Nigeria.<br />
Table 3: HIV status prior to labour and HIV status after testing in labour (<strong>Sagay</strong> et al 2006).<br />
HIV Status prior to Labour Tested HIV Neg in<br />
Labour<br />
22<br />
Tested HIV Pos in<br />
Labour<br />
Negative 230 5 (2.1%) 235<br />
Positive 1 27 28<br />
Unknown 150 16 (9.6%) 166<br />
Indeterminate 0 1 1<br />
Total<br />
381 (88.6%) 49 (11.4%) 430<br />
HIV Sero-discordance among couples in PMTCT settings in Nigeria<br />
In 2005, we conducted this study to determine the pattern <strong>of</strong> HIV sero-status <strong>of</strong> Partners <strong>of</strong><br />
HIV Positive Pregnant Women in three different regions <strong>of</strong> Nigeria and to explore the<br />
implications for HIV prevention interventions. The study was conducted in Benin City, <strong>Jos</strong><br />
and Kano after consideration <strong>of</strong> their ethnic, religious and cultural representation <strong>of</strong> Nigeria.<br />
The city-by-city results showed that in Benin City (Southern Nigeria), 78.8% (104/132) <strong>of</strong><br />
the partners were HIV negative (sero-discordant), <strong>Jos</strong> (Middle-Belt) had 48.4% (103/213)<br />
sero-discordance while Kano (Northern Nigeria) recorded a sero-discordance rate <strong>of</strong> only<br />
7.7% (12/155) (see Figure 8).<br />
Figure 8: Prevalence <strong>of</strong> HIV Sero-discordant Couples with<br />
Positive Female Partners in Nigeria<br />
Oyo<br />
Ogun<br />
Lagos<br />
Kebbi<br />
Osun<br />
Kwara<br />
<strong>Sagay</strong> AS, et al AJMMS 2006<br />
Sokoto<br />
Ekiti<br />
Ondo<br />
Niger<br />
Edo<br />
Delta<br />
Zamfara<br />
Kogi<br />
78.8%<br />
FCT<br />
Anam<br />
bra<br />
Imo<br />
Bayelsa Rivers<br />
Katsina<br />
Kaduna<br />
Abia<br />
Akwa<br />
Ibom<br />
Kano<br />
Nasarawa<br />
Ebonyi<br />
7.7%<br />
Benue<br />
Cross<br />
River<br />
Jigawa<br />
Bauchi<br />
Plateau<br />
48.8%<br />
Taraba<br />
Gombe<br />
Yobe<br />
Adamawa<br />
Borno
The study documented a high prevalence <strong>of</strong> prevalence <strong>of</strong> HIV sero-discordance in marital<br />
settings in Benin and <strong>Jos</strong> and substantiated the observation that unlike most sexually<br />
transmitted diseases (STDs), HIV is not very infectious in heterosexual relationships, unless<br />
the transmission is assisted in some way. The chance in one sexual act <strong>of</strong> transmission<br />
between partners who are disease-free except that one is HIV-positive may be as low as one<br />
in 1000 from woman to man and one in 300 from man to woman (Caldwell et al. 1995).<br />
These are not levels <strong>of</strong> infection which give rise to epidemics, and this is the reason why most<br />
societies with STD control programs are not at risk <strong>of</strong> a heterosexual epidemic. In the United<br />
States only 7% <strong>of</strong> transmission is heterosexual, as is 10% in Europe (Way et al. 1994).<br />
These results also indicate that the dynamics <strong>of</strong> HIV transmission in marital settings in<br />
Nigeria are different in the various regions <strong>of</strong> the country. We concluded as follows, that:<br />
HIV sero-discordance rates in marital settings in Southern Nigeria are among the<br />
highest globally<br />
Studies to unravel the high rate <strong>of</strong> HIV sero-discordance in Benin-City may yield<br />
dividends in the prevention <strong>of</strong> heterosexual transmission in Nigeria. This may not be<br />
unconnected to the almost 100% male circumcision in childhood and easy access to<br />
medical treatment <strong>of</strong> sexually transmitted infections.<br />
In cultures where women are emancipated (Benin), the general direction <strong>of</strong><br />
heterosexual transmission <strong>of</strong> HIV in marital settings is from women to men while the<br />
reverse situation occurs in cultures that are restrictive on women (Kano).<br />
Primary HIV prevention strategies in predominantly Christian communities where<br />
women are emancipated should target young women while Moslem communities<br />
must target the males<br />
Disclosure <strong>of</strong> HIV sero-status in PMTCT settings in Nigeria<br />
Partner consent and support can substantially enhance adherence to PMTCT interventions. This<br />
is particularly true <strong>of</strong> the Nigerian setting where significant others such as mother-in-laws have<br />
a big role in determining postnatal interventions. In this study, we explored the issues<br />
concerning disclosure <strong>of</strong> HIV status to partners <strong>of</strong> HIV sero-positive mothers in our PMTCT<br />
programme in <strong>Jos</strong>, Nigeria.<br />
A total <strong>of</strong> 570 HIV positive mothers in the PMTCT clinic were studied. Eighty nine percent<br />
(500/560) <strong>of</strong> the women have disclosed their HIV status to their partners. Of these, about<br />
40% (199/502) required the assistance <strong>of</strong> health workers while 60% (298/502) did it by<br />
themselves. Following disclosure <strong>of</strong> HIV status, 86.9% (430/495) <strong>of</strong> the partners were<br />
supportive, 5.7% were indifferent, 6.7% were quarrelsome and abusive while 1.0% were<br />
violent. Seventy four percent (419/563) <strong>of</strong> the mothers were aware <strong>of</strong> their husband‘s HIV<br />
sero-status. Of these, 65.4 %( 274/419) <strong>of</strong> the partners were HIV positive while 34.6% were<br />
sero-negative.<br />
Based on these findings, we concluded that the reactions <strong>of</strong> partners <strong>of</strong> HIV positive mothers<br />
to disclosure <strong>of</strong> their wives‘ HIV status are predominantly supportive and felt that this should<br />
strengthen strategies to promote partner disclosure (<strong>Sagay</strong> et al. 2006).<br />
23
Outcome <strong>of</strong> PMTCT interventions in Nigeria<br />
We have analysed the mother-to-child transmission (MTCT) rates following various<br />
interventions at JUTH and these are shown in green bars in figure 9 above. The transmission<br />
rates at 6 weeks <strong>of</strong> age are compared with MTCT rates in Botswana, a country that can boast <strong>of</strong><br />
some <strong>of</strong> the best PMTCT programs in Africa.<br />
15%<br />
10%<br />
5%<br />
0%<br />
Figure 9: ARV Interventions and<br />
MTCT [Nigeria vs. Botswana]<br />
BOTSWANA<br />
JOS, NIGERIA<br />
0.7%<br />
0.9%<br />
2.3%<br />
3.3%<br />
2.9%<br />
Pre-preg During 4wks<br />
HAART AZT+sdNVP<br />
4.7%<br />
24<br />
7.0%<br />
5.2%<br />
sdNVP<br />
alone<br />
12.3%<br />
12.6%<br />
No ART<br />
Clearly, outcomes in our programme are comparable indicating that our interventions are<br />
working like elsewhere in the world.<br />
Infant feeding and MTCT between 6wks and 6months<br />
One <strong>of</strong> the strategies to reduce postnatal mother to child transmission (MTCT) <strong>of</strong> HIV is the use<br />
<strong>of</strong> replacement feeding (BMS) which is expected to eliminate transmission through breast milk.<br />
To achieve this goal, BMS must be practiced in a setting where it is culturally acceptable,<br />
feasible, affordable, sustainable and safe (AFASS), otherwise, there is increased risk <strong>of</strong> infant<br />
morbidity and mortality.<br />
The vast majority <strong>of</strong> our HIV infected mothers are provided with infant formula (BMS) to<br />
prevent HIV transmission to their babies. Our recent unpublished study compared the risk <strong>of</strong><br />
postnatal transmission <strong>of</strong> HIV at 6 months among infants who are HIV negative at 6 weeks <strong>of</strong><br />
age and were exclusively breast fed or given exclusive replacement feeding in the PMTCT<br />
program at JUTH, <strong>Jos</strong>, Nigeria. The difference in transmission risk between the two feeding<br />
methods was not statistically significant (1.8% vs 2.2%; P value =0.785). This finding showed<br />
that many mothers in the BMS group were practicing mixed feeding. New guidelines endorse<br />
administration <strong>of</strong> antiretroviral drugs to make breast feeding safer. It is hoped that this strategy<br />
will improve child survival without increasing HIV transmission to the infant.
Evidence <strong>of</strong> declining prevalence<br />
The last three HIV sero-sentinel surveys have consistently showed a declining trend in HIV<br />
prevalence among pregnant women. HIV prevalence in Plateau State has declined from 8.5%<br />
in 2001 to 2.6% in 2008 (see Figure 10). The reasons are not unconnected with the State-wide<br />
interventions by all stakeholders. I am proud to continue to be part <strong>of</strong> these efforts.<br />
Prevalence (%)<br />
Figure 10: HIV Prevalence trend in States that showed a<br />
defined consistent pattern 2001 - 2008<br />
8.5<br />
8.2<br />
6.8<br />
3.5<br />
3.2<br />
3.3<br />
Key points and Conclusions<br />
9.0<br />
8.0<br />
7.0<br />
6.0<br />
5.0<br />
4.0<br />
3.0<br />
2.0<br />
1.0<br />
0.0<br />
6.8<br />
6.3<br />
4.8<br />
3.7<br />
3.3<br />
2.0<br />
2001 2003 2005 2008<br />
Year<br />
25<br />
4.9<br />
Plateau Bauchi Ekiti Gombe Zamfara Abia<br />
Infertile women in Nigerian face tremendous socio-cultural challenges and perhaps as<br />
a consequence, have a high prevalence <strong>of</strong> psychological problems. Government<br />
support for assisted reproductive technologies, as obtainable in developed countries<br />
like the United Kingdom, may mitigate the impact <strong>of</strong> this widely prevalent malady.<br />
There is no experience more difficult than having to go through a miscarriage time<br />
and time again. Miscarriage is not only physically taxing, but very emotionally<br />
challenging, as well. A small proportion <strong>of</strong> couples in Nigeria experience recurrent<br />
pregnancy losses (when a woman loses three or more consecutive pregnancies). The<br />
management <strong>of</strong> this condition remains a challenge for gynaecologists.<br />
Each year, thousands <strong>of</strong> Nigerian women have unintended pregnancies that end in<br />
illegal abortion. Many <strong>of</strong> such procedures occur under unsafe conditions, contributing<br />
to maternal morbidity and mortality. Substantial investment in culturally appropriate<br />
family planning messaging and making contraception services available, affordable<br />
and accessible to all women (including youths) as a component <strong>of</strong> safe motherhood<br />
programs is required.<br />
4.0<br />
3.4<br />
3.0<br />
1.6<br />
5.0<br />
4.0<br />
3.1<br />
2.6<br />
2.1<br />
1.0
References<br />
Too many mothers and newborns are dying in Nigeria. We know what needs to be done<br />
to save these lives. The real challenges are how to deliver services and scale up interventions,<br />
particularly to those who are vulnerable, hard to reach, marginalized and<br />
excluded. Innovative, non-governmental ways <strong>of</strong> reactivating, supervising and<br />
monitoring services in primary healthcare centres across Nigeria should be a top<br />
priority.<br />
The HIV epidemic is an emerging threat to maternal and newborn lives. Existing<br />
prevention and treatment interventions are efficacious but must be scaled up to<br />
achieve the desired impact.<br />
In Nigeria, the HIV epidemic is driven by heterosexual transmission. In heterosexual<br />
settings, HIV does not stand alone. It requires the support <strong>of</strong> other STDs to stand. This<br />
is why most societies with STD control programs are not at risk <strong>of</strong> a heterosexual<br />
HIV epidemic. In addition to existing HIV interventions, resuscitation <strong>of</strong> STD control<br />
programs nationally is required to control the present HIV scourge.<br />
1. <strong>Sagay</strong> AS, Udoeyop EU, Pam IC, Karshima JA, Daru PH, Otubu J.A.M.<br />
Laparoscopic Evaluation <strong>of</strong> 1000 Consecutive Infertile Women in <strong>Jos</strong>, Nigeria.<br />
Tropical Journal <strong>of</strong> Obstetrics and Gynaecology. 1998, 15(1):30-35.<br />
2. Imade G.E. <strong>Sagay</strong> A.S., Pam I.C., Daru P.H. Semen Quality <strong>of</strong> Male Partners <strong>of</strong><br />
Infertile Couples in <strong>Jos</strong>, Nigeria. Tropical Journal <strong>of</strong> Obstetrics and Gynaecology.<br />
2000, 17(1):24-26.<br />
3. Hollos M, Larsen U, Obono O, Whitehouse B. The problem <strong>of</strong> infertility in high<br />
fertility populations: meanings, consequences and coping mechanisms in two<br />
Nigerian communities. Soc Sci Med. 2009 Jun; 68(11):2061-8.<br />
4. Friday E. Okon<strong>of</strong>ua, Diana Harris, Adetanwa Odebiyi, Thomas Kane and Rachel<br />
C. Snow The social meaning <strong>of</strong> infertility in Southwest Nigeria Health Transition<br />
Review 7, 1997, 205-220.<br />
5. Aghanwa HS, Dare FO, Ogunniyi SO. Sociodemographic factors in mental disorders<br />
associated with infertility in Nigeria. Psychosom Res. 1999 Feb; 46(2):117-23.<br />
6. Guttmacher Institute. In Brief; Reducing unsafe abortion in Nigeria, 2008 Series,<br />
No.3 Pp: 1-4.<br />
7. Bankole A, Oye-Adeniran BA, Singh S, Adewole I, Wulf D, Sedgh G,Hussain R.<br />
Unwanted Pregnancy and Induced Abortion in Nigeria: Causes and Consequences,<br />
New York: Guttmacher Institute, 2006<br />
8. World Health Organization (WHO), Maternal Mortality in 2005: Estimates<br />
Developed by WHO, UNICEF, UNFPA and the World Bank, Geneva: WHO, 2007.<br />
26
9. Henshaw SK, Adewole I, Singh S, Bankole A, Oye-Adeniran B, Hussain R., Severity<br />
and cost <strong>of</strong> unsafe abortion complications treated in Nigerian hospitals, International<br />
Family Planning Perspectives, 2008, 34(1):40–50.<br />
10. World Health Organization (WHO), Maternal Mortality in 2005: Estimates<br />
Developed by WHO, UNICEF, UNFPA, and the World Bank, Geneva: WHO, 2007.<br />
11. Otubu JAM, Towobola AO, Aisien AO, Da’or R, Uguru VE. Female sterilization by<br />
minilaparotomy: The JUTH experience. Trop J Obstet Gynaecol. 1990; 21: 26-28.<br />
12. Aisien AO, Olarewaju RS, Ujah IAO, Mutihir JT, <strong>Sagay</strong> AS. Anaesthesia for<br />
Minilaparotomy Female Sterilization in JUTH, Nigeria: A fourteen-year review.<br />
African Journal <strong>of</strong> Medicine and Medical Sciences. 2001, 30:119-121.<br />
13. Aisien AO, Mutihir JT, Ujah IAO, <strong>Sagay</strong> AS, Imade GE. Fifteen years analysis <strong>of</strong><br />
complications following minilaparotomy female sterilization in <strong>Jos</strong>, Nigeria.<br />
The Nigerian Postgraduate Medical Journal, September 2002; 9 (3):118-122.<br />
14. Otubu JAM, Towobola AO, Aisien AO, Ogunkeye OO. Effects <strong>of</strong> Norplant®<br />
contraceptive subdermal implants on serum lipids and lipoproteins.<br />
Contraception 1993; 47: 149-159.<br />
15. <strong>Sagay</strong> AS, Okeahialam BO, Imade GE. Electrocardiographic changes in Norplant<br />
users in Nigeria. West African Journal <strong>of</strong> Medicine. 2002, 21 (2):146 -148.<br />
16. Okeahialam BN, <strong>Sagay</strong> AS, Imade GE. Prolongation <strong>of</strong> electrocardiographic<br />
intervals in women on Norplant contraceptive: what dangers? African Journal<br />
Medicine and Medical Sciences. 2004, 33: 11-13.<br />
17. Aisien AO, <strong>Sagay</strong> AS, Imade GE, Ujah IAO, Nnana OU. Evaluation <strong>of</strong> Menstrual and<br />
Haematological Parameters after 36 Months <strong>of</strong> Norplant R Contraception. Journal<br />
<strong>of</strong> Obstetrics and Gynaecology 2002; 22(4):406-410.<br />
18. <strong>Sagay</strong> AS, Okeahialam BN, Imade GE , Aisien AO. Evaluation <strong>of</strong> Cardiovascular<br />
Morbidity in Nigerian Women after 3 Years <strong>of</strong> Norplant ® Contraception. African<br />
Journal <strong>of</strong> Reproductive Health, 2008, 12(1):47-53.<br />
19. <strong>Sagay</strong> AS, Imade GE, Aisien AO, Ujah IAO, Muazu MI. Glucose Metabolism in<br />
Norplant users in Northern Nigeria. Contraception. 2000, 62:19-22.<br />
20. VanderJagt DJ, <strong>Sagay</strong> AS, Farmer SE, Imade GE, Glew RH. Effect <strong>of</strong> Norplant<br />
Contraceptive on the Bones <strong>of</strong> Nigerian Women as assessed by Qualitative<br />
Ultrasound and Serum Markers <strong>of</strong> Bone Turnover. Contraception. 2005;72(3):<br />
212-6.<br />
21. Wall LL. Dead mothers and injured wives: the social context <strong>of</strong> maternal morbidity<br />
and mortality among the Hausa <strong>of</strong> northern Nigeria. Stud Fam Plann. 1998<br />
Dec;29(4):341-59.<br />
27
22. Kuti O, Dare FO, Ogunniyi SO. The role <strong>of</strong> referring centres in the tragedy <strong>of</strong><br />
unbooked patients. Trop J Obstet Gynaecol, 2001; 18: 24-26.<br />
23. <strong>Sagay</strong> AS, Ekwempu CC, Kabiru M , Daru PH, Aisien AO. Audit <strong>of</strong> Antenatal Care<br />
in Primary Healthcare Centres (PHCs) In <strong>Jos</strong>, Nigeria. Tropical Journal <strong>of</strong> Obstetrics<br />
and Gynaecology, 2005; 22(2): 147-51.<br />
24. 2008 Nigeria Demographic and Health Survey. National Population Commission,<br />
Abuja. 2010<br />
25. Ujah IAO, Aisien OA, Mutihir JT, Vanderjagt DJ, Glew RH, Uguru VE. Factors<br />
contributing to maternal mortality in North-Central Nigeria: a seventeen-year review.<br />
African Journal <strong>of</strong> Reproductive Health Vol. 9(3) 2005: 27-40.<br />
26. Ref 2. South Africa Every Death Counts Writing Group, Bradshaw D, Chopra M,<br />
Kerber K, Lawn JE, Bamford L, Moodley J, Pattinson R, Patrick M, Stephen C,<br />
Velaphi S. Every death counts: use <strong>of</strong> mortality audit data for decision making to save<br />
the lives <strong>of</strong> mothers, babies, and children in South Africa. Lancet. 2008 Apr<br />
12;371(9620):1294-304.<br />
27. Mairiga AG, Saleh W. Maternal mortality at the State Specialist Hospital Bauchi,<br />
Northern Nigeria. East Afr Med J. 2009 Jan;86(1):25-30.<br />
28. Kullima AA, Kawuwa MB, Audu BM, Geidam AD, Mairiga AG. Trends in maternal<br />
mortality in a tertiary institution in Northern Nigeria. Annals <strong>of</strong> African Medicine<br />
2009, 8( 4):221-224.<br />
29. Bhutta ZA, Ali S, Cousens S, Ali TM, Haider BA, Rizvi A, Okong P, Bhutta SZ,<br />
Black RE. Alma-Ata: Rebirth and Revision 6 Interventions to address maternal,<br />
newborn, and child survival: what difference can integrated primary health care<br />
strategies make? Lancet. 2008 Sep 13; 372(9642):972-89.<br />
30. Sule SS, Onayade AA. Community-based antenatal and perinatal interventions and<br />
newborn survival. Niger J Med. 2006 Apr-Jun; 15(2):108-14.<br />
31. <strong>Sagay</strong> A.S., Imade G.E., Nwokedi E.E. HIV Infection in Pregnant Women in Nigeria.<br />
International Journal <strong>of</strong> Obstetrics and Gynaecology. 1999, 66(2):183-184.<br />
32. Massad LS, Riester KA, Anastos KM, et al Prevalence and predictors <strong>of</strong> squamous<br />
cell abnormalities in Papanicolaou smears from women with HIV I. J Acquir Immune<br />
Defic Syndr hum Retrovirol .1999.21:33-41.<br />
33. Schafer A, Friedman W, Mieke M, Schwartiander B, Koch MA. The increased<br />
frequency <strong>of</strong> cervical dysplasia-neoplasia in women infected with the human<br />
immunodeficiency virus is related to degree <strong>of</strong> immunosuppression. Am J Obstet<br />
Gynecol. 1991; 164:593-599.<br />
28
34. <strong>Sagay</strong> AS, Adisa OJ, Ekwempu CC, Saban S, Ford RW. Prevalence <strong>of</strong> Cervical<br />
Intraepithelial Neoplasia in Different HIV Settings in <strong>Jos</strong>, North-Central Nigeria<br />
Journal <strong>of</strong> Medicine in the Tropics . 2008; 10(2): 41-48.<br />
35. <strong>Sagay</strong> AS, Imade GE, Egah DZ, Onwuliri VA, Adisa J, Grigg MJ, Musa J, Thacher<br />
TD, Potts M, Short R. Genital Tract Abnormalities among Female Sex Workers Who<br />
Douche With Lemon/Lime Juice in Northern Nigeria. African Journal <strong>of</strong><br />
Reproductive Health. 2009; 13(1): 49-57.<br />
36. Moodley D, Moodley J, Coovadia H, et al. A multicenter randomized controlled trial<br />
<strong>of</strong> nevirapine versus a combination <strong>of</strong> zidovudine and lamivudine to reduce<br />
intrapartum and early postpartum MTCT <strong>of</strong> HIV-1. J infect Dis 2003; 167: 725-735.<br />
37. <strong>Sagay</strong> AS, Musa J, Adewole AS, Imade GE, Ekwempu CC, Kapiga SH, Sankale JL,<br />
Idoko JA, Kanki P. Rapid HIV Testing And Counselling In Labour In A Northern<br />
Nigerian Setting. African Journal <strong>of</strong> Reproductive Health. 2006 10(1): 76-80.<br />
38. <strong>Sagay</strong> AS, Onakewhor J, Galadanci H, Emuveyan EE. HIV Status <strong>of</strong> Partners <strong>of</strong> HIV<br />
Positive Pregnant Women in Different Regions <strong>of</strong> Nigeria: Matters Arising. African<br />
Journal Medicine and Medical Sciences, 2006 35, Suppl.: 125-129.<br />
39. John C. Caldwell. Understanding the AIDS Epidemic and Reacting Sensibly To It.<br />
Social Science and Medicine. 1995; 41 (3): 299-302.<br />
40. Way P. O. and Stanecki K. Focusing <strong>of</strong> HIV/AIDS. In Worm Population Pr<strong>of</strong>ile:<br />
1994 (Edited by Jamison E. and Hobbs F.), p. 50. Bureau <strong>of</strong> the Census, Washington<br />
DC, 1994.<br />
41. <strong>Sagay</strong> AS, Musa J, Ekwempu CC, Imade GE, Babalola A, Daniyan G, Malu N, Idoko<br />
JA, Kanki P. Partner Disclosure <strong>of</strong> HIV Status among HIV Positive Mothers in<br />
Northern Nigeria. African Journal Medicine and Medical Sciences, 2006 35, Suppl.:<br />
119-123.<br />
29